You are here:
February 2014: The implementation section was updated to clarify that rituximab is recommended as an option for treating chronic lymphocytic leukaemia. Additional minor maintenance was also carried out.
March 2012: Minor maintenance.
ISBN: 978-1-4731-5630-2